Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives
Globally, Alzheimer’s disease (AD) is one of the most prevalent age-related neurodegenerative disorders associated with cognitive decline and memory deficits due to beta-amyloid deposition (Aβ) and tau protein hyperphosphorylation. To date, approximately 47 million people worldwide have AD. This fig...
Main Authors: | Rajib Das, Abdur Rauf, Saima Akhter, Mohammad Nazmul Islam, Talha Bin Emran, Saikat Mitra, Ishaq N. Khan, Mohammad S. Mubarak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/12/3696 |
Similar Items
-
Discovery of a metabolic alternative to the classical mevalonate pathway
by: Nikki Dellas, et al.
Published: (2013-12-01) -
Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link
by: Paola Maura Tricarico, et al.
Published: (2015-07-01) -
Rôle de la voie mévalonate dans le système nerveux central
by: Pallottini, Valentina
Published: (2017) -
Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions
by: Sneham Tiwari, et al.
Published: (2018-09-01) -
Mevalonate production from ethanol by direct conversion through acetyl-CoA using recombinant Pseudomonas putida, a novel biocatalyst for terpenoid production
by: Jeongmo Yang, et al.
Published: (2019-10-01)